Form 8-K - Current report:
SEC Accession No. 0001564590-20-014534
Filing Date
2020-03-31
Accepted
2020-03-31 16:08:11
Documents
12
Period of Report
2020-03-31
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K crsp-8k_20200331.htm   iXBRL 8-K 54112
  Complete submission text file 0001564590-20-014534.txt   184538

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA crsp-20200331.xsd EX-101.SCH 5776
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE crsp-20200331_lab.xml EX-101.LAB 18649
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crsp-20200331_pre.xml EX-101.PRE 11149
11 EXTRACTED XBRL INSTANCE DOCUMENT crsp-8k_20200331_htm.xml XML 3408
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

EIN.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 20761869
SIC: 2836 Biological Products, (No Diagnostic Substances)